Psyence Biomedical Ltd.
13F holders, Q2 2025 (June 30)5holders
$5.33avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Psyence Biomedical Ltd. in their 13F filings. The largest holders were Sabby Management, LLC ($108K), AdvisorShares Investments LLC ($24K) and Bank of America Corp. ($18K).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F308
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $163K |
| Exits | 0 | $0 |
Ownership 5 holders
| Sabby Management, LLC | 0.88% | New | 20,328 | $108K |
| AdvisorShares Investments LLC | 0.00% | New | 4,448 | $24K |
| Bank of America Corp. | 0.00% | New | 3,340 | $18K |
| UBS Group AG | 0.00% | New | 1,956 | $10K |
| Stonehage Fleming Financial Services Holdings Ltd | 0.00% | New | 561 | $3K |
"% of holder's portfolio" is PSYENCE BIOMEDICAL LTD's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.